Nfe2L2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NFE2L2 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of NFE2L2 is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
Nrf2 is a master regulator of antioxidant response:
- Transcription factor: Regulates expression of antioxidant genes
- Phase II detoxification: Induces detoxifying enzymes
- Proteostasis: Activates proteasome and autophagy genes
- Mitochondrial function: Regulates mitochondrial biogenesis
- Inflammation suppression: Inhibits NF-kB signaling
- Nrf2 activation is neuroprotective
- Impaired Nrf2 signaling in AD
- Therapeutic potential of Nrf2 activators
- Protects dopaminergic neurons
- Nrf2 activators in clinical trials
- Links to oxidative stress
- Dysregulated Nrf2 pathway in ALS
- Potential therapeutic target
- Ubiquitously expressed
- Expressed in all brain cell types
- Activity regulated by oxidative stress
- 10488963: Nrf2 as master regulator of antioxidant response. Nat Rev Drug Discov, 2009.
- 25622800: Nrf2 in neurodegeneration. Nat Rev Neurol, 2015.
The study of Nfe2L2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Li E et al.. "CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions." Neuron (2025). DOI: 10.1016/j.neuron.2024.12.016 PubMed: 39814010
- Deng PX et al.. "Artemisinin inhibits neuronal ferroptosis in Alzheimer's disease models by targeting KEAP1." Acta pharmacologica Sinica (2025). DOI: 10.1038/s41401-024-01378-6 PubMed: 39251858
- Cheng M et al.. "Quercetin Attenuates Oxidative Stress and Apoptosis in Brain Tissue of APP/PS1 Double Transgenic AD Mice by Regulating Keap1/Nrf2/HO-1 Pathway to Improve Cognitive Impairment." Behavioural neurology (2024). DOI: 10.1155/2024/5698119 PubMed: 39233848
- Gao Y et al.. "Targeting the bile acid receptor TGR5 with Gentiopicroside to activate Nrf2 antioxidant signaling and mitigate Parkinson's disease in an MPTP mouse model." Journal of advanced research (2026). DOI: 10.1016/j.jare.2025.05.039 PubMed: 40414345
- Jia H et al.. "Repurposing of epalrestat for neuroprotection in parkinson's disease via activation of the KEAP1/Nrf2 pathway." Journal of neuroinflammation (2025). DOI: 10.1186/s12974-025-03455-x PubMed: 40301912
- Zhu M et al.. "The NFE2L2 rs35652124 polymorphism and the risk of Parkinson's disease: a systematic review and meta-analysis." Neuroreport (2016). DOI: 10.1097/WNR.0000000000000627 PubMed: 27306592
- Ding T et al.. "Schisandrin B ameliorates Alzheimer's disease by suppressing neuronal ferroptosis and ensuing microglia M1 polarization." Phytomedicine (2025). DOI: 10.1016/j.phymed.2025.156780 PubMed: 40382817
- Uruno A, Yamamoto M. "The KEAP1-NRF2 System and Neurodegenerative Diseases." Antioxidants & redox signaling (2023). DOI: 10.1089/ars.2023.0234 PubMed: 36930785